Profile
BDXB ISRG BDXA BDX ALC RMD
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $13.69B $183.74B $53.11B $49.57B $44.11B $40.72B
Employees 77.00K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Thomas E. Polen Jr. Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
BDXB ISRG BDXA BDX ALC RMD
Quant Rating Score 4 3 5 3 3 4
Quant Rating Buy Neutral Strong Buy Neutral Neutral Buy
Trading
BDXB ISRG BDXA BDX ALC RMD
Last Close $48.16 $483.12 $59.24 $176.37 $87.87 $279.2
High 52 $48.16 $610.45 $59.24 $249.08 $100.76 $279.2
Low 52 $48.16 $438 $59.24 $165.15 $82.73 $204.58
Price vs. 52 Week High 0 % -20.86 % 0 % -29.19 % -12.79 % 0 %
Price vs. 52 Week Low 0 % 10.3 % 0 % 6.79 % 6.21 % 36.47 %
Total Return
BDXB ISRG BDXA BDX ALC RMD
1 Month Return 0 % -10.65 % 0 % -0.51 % -1.6 % 9.09 %
3 Month Return 0 % -8.75 % 0 % 4.5 % -10.61 % 16.36 %
6 Month Return 0 % -15.52 % 0 % -28.77 % -3.53 % 18.21 %
9 Month Return 0 % -4.59 % 0 % -25.03 % -4.27 % 14.3 %
YTD Return 0 % -7.44 % 0 % -22.26 % 3.51 % 22.09 %
1 Year Return 0 % 7.42 % 0 % -27.08 % -4.88 % 24.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXB ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) 2.24 % - 2.28 % 2.35 % 0.37 % 0.76 %
Dividend Paid and Capex Coverage Ration (TTM) 1.77 % 2.77 % 1.77 % 1.77 % 3.43 % 4.21 %
Dividend Per Share (TTM) 4.07 % - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) 76.77 % - 76.77 % 76.77 % 11.23 % 23.14 %
Profitability
BDXB ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 44.5 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM 2.75 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM 5.86 % 15.52 % 5.86 % 5.86 % 5.22 % 25.18 %
Return on Capital Employed TTM 5.05 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 89.01 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 71.19 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM 11.33 % 28.2 % 11.33 % 11.33 % 15.24 % 32.1 %
Cash Flow To Debt Ratio TTM 17.12 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 6.89 6.46 6.89 6.89 5.34 5.53
Payables Turnover TTM - 10.39 - - 5.24 9.36
Inventory Turnover TTM 3.11 1.85 3.11 3.11 1.88 2.41
Fixed Asset Turnover TTM 313.98 % 181.6 % 313.98 % 313.98 % 202.43 % 729.93 %
Asset Turnover TTM 38.31 % 45.34 % 38.31 % 38.31 % 32.01 % 66.36 %
Operating Cash Flow Per Share TTM 11.44 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM 8.98 4.88 8.98 8.98 3.26 10.66
Cash Per Share TTM 236.81 % 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM 15.81 % 31.34 % 15.81 % 15.81 % 21.17 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.51 % 63.9 % 78.51 % 78.51 % 76.82 % 94.64 %
Cash Flow Coverage Ratios TTM 17.12 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM 20.09 105.28 19.72 19.14 27.32 26.03
Price To Operating Cash Flows Ratio TTM 15.87 67.1 15.58 15.12 21.01 24.65
Price Cash Flow Ratio TTM 15.87 67.1 15.58 15.12 21.01 24.65
Income Statement (TTM)
BDXB ISRG BDXA BDX ALC RMD
Revenue $20.18B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $9.13B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 45.22% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $4.82B $2.81B $4.82B $4.82B $2.68B $1.69B
Net Income $1.71B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 5.86 6.42 5.86 5.86 2.05 -
Balance Sheet (MRQ)
BDXB ISRG BDXA BDX ALC RMD
Long Term Debt $17.94B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $31.4B $2.31B $31.4B $31.4B $8.79B $2.01B
Total Equity $25.89B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0.45B $7.05B $0.45B $0.45B $0.91B $0.17B
Total Debt $20.11B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $57.29B $18.84B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
BDXB ISRG BDXA BDX ALC RMD
Net Income $1.71B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0.1B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $-1.1B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $3.8B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXA Becton, Dickinson and Company 59.24
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
DXR Daxor Corporation 9.45
EKSO Ekso Bionics Holdings, Inc. 3.49
FEMY Femasys Inc. 0.8196
GCTK GlucoTrack, Inc. 6.23
ETFs With Exposure to BDXB
Ticker ETF Name Weight Percentage Price
FCVT First Trust SSI Strategic Convertible Securities ETF 0.39 39.1256
HSUN Hartford Sustainable Income ETF 0.134074 33.534
QPFF American Century Quality Preferred ETF 0.68 35.6762
Unlock